0001672688-24-000013.txt : 20240205 0001672688-24-000013.hdr.sgml : 20240205 20240205191407 ACCESSION NUMBER: 0001672688-24-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240205 DATE AS OF CHANGE: 20240205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Busch Andreas CENTRAL INDEX KEY: 0001775029 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40646 FILM NUMBER: 24597529 MAIL ADDRESS: STREET 1: C/O CYCLERION THERAPEUTICS, INC. STREET 2: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Absci Corp CENTRAL INDEX KEY: 0001672688 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 853383487 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18105 SE MILL PLAIN BLVD CITY: VANCOUVER STATE: WA ZIP: 98683 BUSINESS PHONE: (360) 949-1041 MAIL ADDRESS: STREET 1: 18105 SE MILL PLAIN BLVD CITY: VANCOUVER STATE: WA ZIP: 98683 FORMER COMPANY: FORMER CONFORMED NAME: AbSci Corp DATE OF NAME CHANGE: 20201026 FORMER COMPANY: FORMER CONFORMED NAME: AbSci, Inc. DATE OF NAME CHANGE: 20201026 FORMER COMPANY: FORMER CONFORMED NAME: AbSci, LLC DATE OF NAME CHANGE: 20160420 4 1 wk-form4_1707178418.xml FORM 4 X0508 4 2024-02-01 0 0001672688 Absci Corp ABSI 0001775029 Busch Andreas C/O ABSCI CORPORATION 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683 0 1 0 0 Chief Innovation Officer 0 Common Stock 2024-02-01 4 A 0 83125 0 A 258125 D Stock Option (right to buy) 4.40 2024-02-01 4 A 0 349625 0 A 2034-01-31 Common Stock 349625 349625 D The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in three substantially equal annual installments with the first such annual installment vesting on February 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date. The shares subject to this option shall vest and become exercisable over a three year period, in substantially equal annual installments with the first such installment vesting on February 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date. /s/ Todd Bedrick, attorney-in-fact 2024-02-05